These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1717021)

  • 21. Maternal serum alpha-fetoprotein and fetal autosomal trisomies.
    Doran TA; Cadesky K; Wong PY; Mastrogiacomo C; Capello T
    Am J Obstet Gynecol; 1986 Feb; 154(2):277-81. PubMed ID: 2418684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal alpha-fetoprotein screening for Down's syndrome.
    Pueschel SM
    N Engl J Med; 1987 Aug; 317(6):376-8. PubMed ID: 2439910
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].
    Arbuzova SB; Nikolenko MI
    Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gynecological aspects of prenatal diagnosis of congenital anomalies (author's transl)].
    Knörr K; Jonatha WD; Tettenborn U
    MMW Munch Med Wochenschr; 1976 May; 118(19):589-94. PubMed ID: 132608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prenatal chromosome analysis using the FISH technique allows fetal aneuploidy detection within a few hours].
    Steinborn A; Röddiger S; Born HJ; Baier P; Halberstadt E
    Z Geburtshilfe Neonatol; 1996; 200(5):186-90. PubMed ID: 9035828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
    Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
    Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical analysis of the amniotic fluid in early amniocentesis. Importance of alpha-fetoproteins].
    Aimone V
    Minerva Ginecol; 1980 Jun; 32(6):539-44. PubMed ID: 6165937
    [No Abstract]   [Full Text] [Related]  

  • 30. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
    Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B
    Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prenatal investigations for Down's syndrome: medical-technical considerations and dilemmas arising from current screening methods].
    Grijseels EW; Laudy JA; Galjaard RJ; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2166-71. PubMed ID: 15559409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.
    Benn PA; Horne D; Briganti S; Greenstein RM
    Am J Obstet Gynecol; 1995 Aug; 173(2):496-501. PubMed ID: 7544068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1994 Oct; 14(10):963-71. PubMed ID: 7534926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal genetic diagnosis of Down's syndrome.
    Abbott MA; Benn P
    Expert Rev Mol Diagn; 2002 Nov; 2(6):605-15. PubMed ID: 12465456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
    Wenstrom KD; Desai R; Owen J; DuBard MB; Boots L
    Am J Obstet Gynecol; 1995 Oct; 173(4):1287-92. PubMed ID: 7485339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seeking other disorders within antenatal serum screening programmes for Down's syndrome.
    Wald NJ; Canick JA
    J Med Screen; 2002; 9(4):145-6. PubMed ID: 12518002
    [No Abstract]   [Full Text] [Related]  

  • 38. Femur length in the US prediction of trisomy 21 and other chromosomal abnormalities.
    Grist TM; Fuller RW; Albiez KL; Bowie JD
    Radiology; 1990 Mar; 174(3 Pt 1):837-9. PubMed ID: 2137635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-fetoprotein in fetal serum, amniotic fluid, and maternal serum.
    Van Lith JM; Beekhuis JR; Van Loon AJ; Mantingh A; De Wolf BT; Breed AS
    Prenat Diagn; 1991 Aug; 11(8):625-8. PubMed ID: 1722580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved screening for fetal chromosome abnormalities.
    Williamson R
    Iowa Med; 1990 Mar; 80(3):125-8. PubMed ID: 1690690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.